Viewing Study NCT05201118


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
Study NCT ID: NCT05201118
Status: UNKNOWN
Last Update Posted: 2022-05-24
First Post: 2022-01-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
Sponsor: Chunrui Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module